stock pickSLNOemail_stock_pick
Portnoy Law Firm Targets SLNO Investors: Act Now!
# Portnoy Law Firm Targets SLNO Investors: Act Now!
Read moreFeatured By
Research
In-depth company research, stock analysis, and market opportunities from the Smart Investors Daily research team.
# Portnoy Law Firm Targets SLNO Investors: Act Now!
Read more# KROS: New Data on Rinvatercept at 2026 MDA Conference!
Read more# MPC: Don't Miss This After Positive Phase 3 Data! ## Introduction Marathon Petroleum Corporation (NYSE: MPC) – the largest independent U.S.
Read more# TGTX: BRIUMVI® Data Shows Major MS Breakthrough! ## Overview – *Briumvi’s MS Breakthrough and Company Background* TG Therapeutics, Inc. (NASDAQ: **TGTX**) is a biopharmaceutical…
Read more# VALN: Full Year 2025 Results Drop on March 18, 2026!
Read more# ACTU: Strategic Research Initiative Could Boost Gains! ## Company Overview Actuate Therapeutics, Inc.
Read more# KYNB: Q4 2025 Results Could Spark Major Market Moves!
Read more# FGEN: Kyntra Bio’s 2025 Results Could Shift Markets! **(Ticker: FGEN, now Nasdaq: KYNB)** – *Senior Equity Analyst Report for Unknown Publisher* ## Company Background and Recent…
Read more# HPE: AI Orders Surge Amid Memory Shortages! ## Overview – Surging AI Demand vs. Supply Constraints Hewlett Packard Enterprise (HPE) is riding a wave of demand for AI-focused…
Read more# ORIS: Unlock Sustainable Gains with Agro-Solar Integration!
Read more# PYPL: $9B Loss Sparks Class Action — What’s Next?
Read more# NOW: Uncover S02E14's High Potential Insights!
Read more# SLNO: Urgent Action Needed – Class Action Deadline Approaches!
Read more# INKT: New Collaboration to Boost Pediatric Cancer Therapy! ## Collaboration Catalyzes Pediatric Cancer Program MiNK Therapeutics (NASDAQ: **INKT**) is a clinical-stage biotech…
Read more# INVESTOR ALERT: Pomerantz Investigates NVO Claims! **Novo Nordisk A/S (NYSE: NVO)** – the Danish pharmaceutical giant behind blockbuster diabetes and weight-loss drugs Ozempic…
Read more# BSX Alert: Investigation Could Impact Long-Term Value! **Boston Scientific Corporation (NYSE: BSX)** – a leading medical device maker – faces new challenges as an investigation…
Read more# MREO: Act Now! Secure Counsel Before Class Action Deadline!
Read more# CAPR: New PDUFA Date Could Unlock Major Gains! ## Company Overview Capricor Therapeutics (NASDAQ: **CAPR**) is a clinical-stage biotech focused on rare disease treatments,…
Read more# Overview & Fortrea Connection Citigroup Inc. (NYSE: C) – one of the world’s largest diversified banks – is in the midst of a multi-year transformation under CEO Jane Fraser.
Read more# Background: Class Action and Trial Setback VistaGen Therapeutics (NASDAQ: VTGN) is facing a shareholder class action lawsuit after a major setback in its lead drug’s Phase 3…
Read more